Consensus Rating1
Buy
Highest Price Target1
$35.00
Lowest Price Target1
$5.00
Consensus Price Target1
$15.44

Immunic (NASDAQ:IMUX) Stock, Analyst Ratings, Price Targets, Forecasts

Immunic Inc has a consensus price target of $15.44 based on the ratings of 9 analysts. The high is $35 issued by Aegis Capital on August 8, 2022. The low is $5 issued by Leerink Partners on September 9, 2024. The 3 most-recent analyst ratings were released by EF Hutton, EF Hutton, and Leerink Partners on September 18, 2024, September 16, 2024, and September 9, 2024, respectively. With an average price target of $13 between EF Hutton, EF Hutton, and Leerink Partners, there's an implied 598.92% upside for Immunic Inc from these most-recent analyst ratings.

Analyst Trends and Forecast
0
0
0
0
Apr
1
Jul
0
0
0
0
Aug
1
Sep
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
3.8
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

EF Hutton
Leerink Partners
B. Riley Securities
Piper Sandler
Brookline Capital

1calculated from analyst ratings

Analyst Ratings for Immunic

Data brought to you by Benzinga APIs

FAQ

Q

What is the target price for Immunic (IMUX) stock?

A

The latest price target for Immunic (NASDAQ:IMUX) was reported by EF Hutton on September 18, 2024. The analyst firm set a price target for $17.00 expecting IMUX to rise to within 12 months (a possible 813.98% upside). 7 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Immunic (IMUX)?

A

The latest analyst rating for Immunic (NASDAQ:IMUX) was provided by EF Hutton, and Immunic maintained their buy rating.

Q

When was the last upgrade for Immunic (IMUX)?

A

There is no last upgrade for Immunic

Q

When was the last downgrade for Immunic (IMUX)?

A

The last downgrade for Immunic Inc happened on October 21, 2022 when SVB Leerink changed their price target from $9 to $5 for Immunic Inc.

Q

When is the next analyst rating going to be posted or updated for Immunic (IMUX)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Immunic, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Immunic was filed on September 18, 2024 so you should expect the next rating to be made available sometime around September 18, 2025.

Q

Is the Analyst Rating Immunic (IMUX) correct?

A

While ratings are subjective and will change, the latest Immunic (IMUX) rating was a maintained with a price target of $17.00 to $17.00. The current price Immunic (IMUX) is trading at is $1.86, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch